You'd have thought that this announcement miiiiiight just have been considered price sensitive??Definitely good news in my book.Do we think that this might have been one of the announcements that FT had previously mentioned?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%